DMII NASDAQ
Drugs Made In America Acquisition II Corp. Ordinary Shares
1W: +0.1%
1M: +0.4%
3M: +0.8%
YTD: +3.0%
$10.20
+0.00 (+0.00%)
After Hours: $10.23 (+0.03, +0.25%)
Weekly Expected Move ±0.1%
$10
$10
$10
$10
$10
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$649.7M
52W Range9.86-10.33
Volume0
Avg Volume109,930
Beta0.04
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
Employees2
SectorFinancial Services
IndustryFinancial - Conglomerates
IPO Date2025-12-04
Websitedmaacorp.com/
420 Lexington Avenue
New York, NY 10170
US
New York, NY 10170
US
954 870 3099
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Do Catherine | J-Other | 100,000 | — | 2025-09-26 |
| Shulgan Myron W. | J-Other | 100,000 | — | 2025-09-26 |
| Worman Glenn C. | J-Other | 100,000 | — | 2025-09-26 |